As a second possible therapeutic correlate, reduced expression of RNA coding for IgA1, IgA2, and J chain (Figure 4B) may reflect depletion of potentially pathogenic IgA+ B cells which mediate inflammatory diseases including MS, and traffic to the CNS (1, 7, 44). This evidence concerns the gene IGHA1 and myeloid sarcoma.